Hepatitis C News and Research

Latest Hepatitis C News and Research

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

A new study presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases - found that eradication of the hepatitis C virus induced by direct‐acting antiviral medications is associated with a 71 percent reduction in the risk of liver cancer.

20 Oct 2017

Study examines risk of using liver organs from hepatitis C positive donors

Use of liver organs from selected hepatitis C positive donors should be considered due to modest risk of hepatitis C transmission and the availability of safe and effective direct‐acting antiviral therapies, according to research presented this week at The Liver Meeting -; held by the American Association for the Study of Liver Diseases.

20 Oct 2017

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

20 Oct 2017

Increased use of split liver transplantation could decrease pediatric waitlist deaths

A new study presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases - found that increased utilization of split liver transplantation (sharing a donor liver between one pediatric and one adult patient) could decrease the number of children who die awaiting liver transplantation without decreasing liver transplantation access for adult patients.

20 Oct 2017

HCV screening or diagnosis could lower non‐prescribed opioid use

Research presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

20 Oct 2017

Study finds rise in pregnancy rates among women with chronic liver disease

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that the overall number of pregnancies in women with chronic liver disease or following liver transplantation has risen over the past 30 years.

20 Oct 2017

On back roads of Appalachia’s coal country, mental health services are as rare as jobs

Every other month, Tanya Nelson travels 32 miles from the heart of Appalachia's coal country for an appointment with the nearest psychiatrist for therapy and to renew prescriptions. But the commute, which should take less than an hour through the winding mountain roads of southern West Virginia, consumes her entire day.

17 Oct 2017

Report sheds light on global market for infectious disease immunoassays

Kalorama Information says that infectious disease immunoassays beat the IVD market and the overall IVD market in terms of revenue growth. Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance.

16 Oct 2017

NTNU researchers reveal how HCV converts innocent cells into virus factories

The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus "factories" that quickly go into mass production.

13 Oct 2017

Study reveals unique norovirus characteristic of hiding from host immune system

Noroviruses are the leading cause of non-bacterial gastroenteritis in the world and are estimated to cause 267 million infections and 20,000 deaths each year. This virus causes severe diarrhea, nausea, and stomach pain.

11 Oct 2017

Donor organs labeled as increased risk less likely to be used by transplant patients

Increasingly, transplant surgeons must initiate a tough conversation: explaining to patients what it means to accept an organ from a person who died from a drug overdose.

5 Oct 2017

Hepatitis C drug’s lower cost paves way for Medicaid, prisons to expand treatment

Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn't qualify yet for the Medicaid program's criteria for treatment with a new class of highly effective but pricey drugs. The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.

3 Oct 2017

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

27 Sep 2017

CDC warns about steep rise in STDs among Americans

According to a statement from the Centers for Disease Control and Prevention yesterday (26th September 2017), in 2016, a survey has revealed that more than 2 million Americans have been diagnosed with a sexually transmitted disease (STD) including infections such as gonorrhea, syphilis and Chlamydia. This is one of the highest numbers that have been detected till date they say.

27 Sep 2017

California scrambles to contain ‘unprecedented’ hepatitis A outbreaks

Health officials in California are struggling to contain fierce outbreaks of hepatitis A among homeless people and drug abusers in three counties, including San Diego, where at least 17 people have died.

26 Sep 2017

Vaccine to prevent Lyme disease on the cards

Lyme disease is an infection that spreads with the bites of an infected tick. For the past four years, a vaccine to protect dogs from this disease has been available. Now, vaccinating humans against this disease has also become a possibility.

26 Sep 2017

Drinking three or more cups of coffee a day linked to reduced mortality risk in HIV-HCV patients

Patients infected by both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at specific risk of end-stage liver disease and greater risk of cardiovascular diseases and cancer.

25 Sep 2017

Routine and rapid HCV testing improves life expectancy, reduces costs for young adults

Routine and rapid hepatitis C virus testing among young adults who use injection drugs improves life expectancy and may provide a good use of limited resources, according to new research out of Boston Medical Center, in partnership with the Boston Public Health Commission.

21 Sep 2017

Teen tattoos - an issue raising concern

According to a clinical report by the American Academy of Pediatrics, “voluntary body modifications” or tattoos, scarifications and piercings by teenagers is a rising concern. These can lead to serious complications they warn and also discuss the implications of these modifications both in terms of social as well as personal and related to mental health.

19 Sep 2017

Scientists make significant discovery in efforts to develop vaccine against global pathogens

Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

15 Sep 2017

Hepatitis C News and Research

Latest Hepatitis C News and Research

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

Study examines risk of using liver organs from hepatitis C positive donors

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

Increased use of split liver transplantation could decrease pediatric waitlist deaths

HCV screening or diagnosis could lower non‐prescribed opioid use

Study finds rise in pregnancy rates among women with chronic liver disease

On back roads of Appalachia’s coal country, mental health services are as rare as jobs

Report sheds light on global market for infectious disease immunoassays

NTNU researchers reveal how HCV converts innocent cells into virus factories

Study reveals unique norovirus characteristic of hiding from host immune system

Donor organs labeled as increased risk less likely to be used by transplant patients

Hepatitis C drug’s lower cost paves way for Medicaid, prisons to expand treatment

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

CDC warns about steep rise in STDs among Americans

California scrambles to contain ‘unprecedented’ hepatitis A outbreaks

Vaccine to prevent Lyme disease on the cards

Drinking three or more cups of coffee a day linked to reduced mortality risk in HIV-HCV patients

Routine and rapid HCV testing improves life expectancy, reduces costs for young adults

Teen tattoos - an issue raising concern

Scientists make significant discovery in efforts to develop vaccine against global pathogens

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in